✦ LIBER ✦

Histone deacetylase inhibitors: discovery and development as anticancer agents

✍ Scribed by Marks, Paul A; Dokmanovic, Milos

Book ID: 121251729
Publisher: Informa plc
Year: 2005
Tongue: English
Weight: 275 KB
Volume: 14
Category: Article
ISSN: 1354-3784
DOI: 10.1517/13543784.14.12.1497

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

CLINICAL DEVELOPMENT OF HISTONE DEACETYL

CLINICAL DEVELOPMENT OF HISTONE DEACETYLASE INHIBITORS AS ANTICANCER AGENTS*

✍ Drummond, Daryl C.; Noble, Charles O.; Kirpotin, Dmitri B.; Guo, Zexiong; Scott, 📂 Article 📅 2005 🏛 Annual Reviews 🌐 English ⚖ 517 KB

Histone deacetylase inhibitors: Multifun

Histone deacetylase inhibitors: Multifunctional anticancer agents

✍ Tao Liu; Selena Kuljaca; Andrew Tee; Glenn M. Marshall 📂 Article 📅 2006 🏛 Elsevier Science 🌐 English ⚖ 151 KB

Rational Development of Histone Deacetyl

Rational Development of Histone Deacetylase Inhibitors as Anticancer Agents: A Review

✍ Acharya, Milin R. (author);Sparreboom, Alex (author);Venitz, Jürgen (author);Fig 📂 Article 📅 2005 🏛 American Society for Pharmacology and Experimental 🌐 English ⚖ 171 KB

Rational Development of Histone Deacetyl

Rational Development of Histone Deacetylase Inhibitors as Anticancer Agents: A Review

✍ Acharya, Milin R. (author);Sparreboom, Alex (author);Venitz, Jürgen (author);Fig 📂 Article 📅 2005 🏛 American Society for Pharmacology and Experimental 🌐 English ⚖ 171 KB

Histone deacetylase inhibitors (HDACIs):

Histone deacetylase inhibitors (HDACIs): multitargeted anticancer agents

✍ Licciardi, Paul; Ververis, ; Hiong, ; Karagiannis, 📂 Article 📅 2013 🏛 Dove Press Ltd. 🌐 English ⚖ 790 KB

Dietary agents as histone deacetylase in

Dietary agents as histone deacetylase inhibitors

✍ Melinda C. Myzak; Emily Ho; Roderick H. Dashwood 📂 Article 📅 2006 🏛 John Wiley and Sons 🌐 English ⚖ 109 KB

## Abstract In cancer cells, an imbalance often exists between histone acetyltransferase (HAT) and histone deacetylase (HDAC) activities, and various drug companies are actively seeking competitive HDAC inhibitors for chemotherapeutic intervention. Cancer cells appear to be more sensitive than nont